REFERENCES

1. Cicione A, De Nunzio C, Lombardo R, et al. Complications and quality of life of ileal conduit, orthotopic neobladder and ureterocutaneostomy: systematic review of reports using the Clavien-Dindo Classification. Minerva Urol Nefrol 2020;72:408-19.

2. Alfred WJ, Lebret T, Comperat EM, et al. Updated 2016 EAU Guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 2017;71:462-75.

3. Mitropoulos D, Artibani W, Graefen M, et al. Reporting and grading of complications after urologic surgical procedures: An ad hoc EAU Guidelines Panel Assessment and Recommendations. Eur Urol 2012;61:341-9.

4. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.

5. Eswara JR, Efstathiou JA, Heney NM, et al. Complications and long-term results of salvage cystectomy after failed bladder sparing therapy for muscle invasive bladder cancer. J Urol 2012;187:463-8.

6. George L, Bladou F, Bardou VJ, et al. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy. Urology 2004;64:488-93.

7. Linell O. Salvage cystectomy. Review of 19 cases. Eur Urol 1987;13:17-21.

8. Konnak JW, Barton Grossman H. Salvage cystectomy following failed definitive radiation therapy for transitional cell carcinoma of bladder. Urology 1985;26:550-3.

9. Smith JA, Whitmore WF. Salvage cystectomy for bladder cancer after failure of definitive irradiation. J Urol 1981;125:643-5.

10. Kulkarni GS, Hermanns T, Wei Y, et al. Propensity score analysis of radical cystectomy versus bladder-sparing trimodal therapy in the setting of a multidisciplinary bladder cancer clinic. J Clin Oncol 2017;35:2299-305.

11. Cooke PW, Dunn JA, Latief T, Bathers S, James ND, Wallace DMA. Long-term risk of salvage cystectomy after radiotherapy for muscle-invasive bladder cancer. Eur Urol 2000;38:279-86.

12. Nieuwenhuijzen JA, Horenblas S, Meinhardt W, Van Tinteren H, Moonen LMF. Salvage cystectomy after failure of interstitial radiotherapy and external beam radiotherapy for bladder cancer. BJU Int 2004;94:793-7.

13. Bochner BH, Figueroa AJ, Skinner EC, et al. Salvage radical cystoprostatectomy and orthotopic urinary diversion following radiation failure. J Urol 1998;160:29-33.

14. Crawford ED, Skinner DG. Salvage cystectomy after irradiation failure. J Urol 1980;123:32-4.

15. Freiha FS, Faysal MH. Salvage cystectomy. Urology 1983;22:496-8.

16. Swanson DA, von Eschenbach AC, Bracken RB, Johnson DE. Salvage cystectomy for bladder carcinoma. Cancer 1981;47:2275-9.

17. Abratt RP, Wilson JA, Pontin AR, Barnes RD. Salvage cystectomy after radical irradiation for bladder cancer-prognostic factors and complications. Br J Urol 1993;72:756-60.

18. Nurmi M, Valavaara R, Puntala P, Ekfors T. Single-stage salvage cystectomy: results and complications in 20 patients. Eur Urol 1989;16:89-91.

19. Rödel C, Grabenbauer GG, Kühn R, et al. Organ preservation in patients with invasive bladder cancer: Initial results of an intensified protocol of transurethral surgery and radiation therapy plus concurrent cisplatin and 5-fluorouracil. Int J Radiat Oncol Biol Phys 2002;52:1303-9.

20. Polo-Alonso E, Kuk C, Guruli G, et al. Trimodal therapy in muscle invasive bladder cancer management. Minerva Urol Nefrol 2020;72:650-62.

21. Mak RH, Hunt D, Shipley WU, et al. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of radiation therapy oncology group protocols 8802, 8903, 9506, 9706, 9906, and 0233. J Clin Oncol 2014;32:3801-9.

22. Schuettfort VM, Pradere B, Quhal F, et al. Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis. World J Urol 2020; doi: 10.1007/s00345-020-03436-0.

23. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001;19:666-75.

24. Martini A, Sfakianos JP, Renström-Koskela L, et al. The natural history of untreated muscle-invasive bladder cancer. BJU Int 2020;125:270-5.

25. Zebic N, Weinknecht S, Kroepfl D. Radical cystectomy in patients aged ≥ 75 years: an updated review of patients treated with curative and palliative intent. BJU Int 2005;95:1211-4.

26. Nagele U, Anastasiadis AG, Merseburger AS, et al. The rationale for radical cystectomy as primary therapy for T4 bladder cancer. World J Urol 2007;25:401-5.

27. Cochetti G, Barillaro F, Boni A, Mearini E. Immediate radical cystectomy for massive bleeding of bladder cancer. Biomed Res Int 2015;2015:154392.

28. De Nunzio C, Cicione A, Izquierdo L, et al. Multicenter analysis of postoperative complications in octogenarians after radical cystectomy and ureterocutaneostomy: the role of the frailty index. Clin Genitourin Cancer 2019;17:402-7.

29. Lacarrière E, Smaali C, Benyoucef A, Pfister C, Grise P. The efficacy of hemostatic radiotherapy for bladder cancer-related hematuria in patients unfit for surgery. Int Braz J Urol 2013;39:808-16.

30. Wujanto C, Tey J, Chia D, et al. Radical radiotherapy in older patients with muscle invasive bladder cancer. J Geriatr Oncol 2019;10:292-7.

31. Abt D, Bywater M, Engeler DS, Schmid HP. Therapeutic options for intractable hematuria in advanced bladder cancer. Int J Urol 2013;20:651-60.

32. Loffroy R, Pottecher P, Cherblanc V, et al. Current role of transcatheter arterial embolization for bladder and prostate hemorrhage. Diagn Interv Imaging 2014;95:1027-34.

33. Mohan S, Kumar S, Dubey D, Phadke RV, Baijal SS, Kathuria M. Superselective vesical artery embolization in the management of intractable hematuria secondary to hemorrhagic cystitis. World J Urol 2019;37:2175-82.

34. Ramani VAC, Maddineni SB, Grey BR, Clarke NW. Differential complication rates following radical cystectomy in the irradiated and nonirradiated pelvis. Eur Urol 2010;57:1058-63.

35. Iwai A, Koga F, Fujii Y, et al. Perioperative complications of radical cystectomy after induction chemoradiotherapy in bladder-sparing protocol against muscle-invasive bladder cancer: a single institutional retrospective comparative study with primary radical cystectomy. Jpn J Clin Oncol 2011;41:1373-9.

36. Eisenberg MS, Dorin RP, Bartsch G, Cai J, Miranda G, Skinner EC. Early complications of cystectomy after high dose pelvic radiation. J Urol 2010;184:2264-9.

37. Gontero P, Pisano F, Palou J, et al. Complication rate after cystectomy following pelvic radiotherapy: an international, multicenter, retrospective series of 682 cases. World J Urol 2020;38:1959-68.

38. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med 2003;349:2117-27.

39. Nielsen ME, Mallin K, Weaver MA, et al. Association of hospital volume with conditional 90-day mortality after cystectomy: an analysis of the National Cancer Data Base. BJU Int 2014;114:46-55.

40. Mak RH, Zietman AL, Heney NM, Kaufman DS, Shipley WU. Bladder preservation: Optimizing radiotherapy and integrated treatment strategies. BJU Int 2008;102:1345-53.

41. De Nunzio C, Cindolo L, Leonardo C, et al. Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort. Eur J Surg Oncol 2013;39:792-8.